Virus-based technologies

Understanding infection mechanisms of viruses, diagnosing them and developping approaches for targeted prevention (vaccines) and therapy (oncolytic viruses) are our central concerns.

The research group develops virus-based therapies. We provide virus-like particles with antigens for use as vaccines or develop them as vehicles for targeted drug delivery.

Bacteriophages are viruses that specifically and exclusively destroy bacteria. They can be used for therapeutic purposes, for bacterial diagnostics and to break down biofilms. We are dealing with the groundbreaking topic of their application-related use for targeted germ reduction.

With our experience and infrastructure we offer the cultivation and production of selected viruses. For characterization and further investigation a number of assays are available.

PCR-based technologies form the basis for rapid identification and quantification of pathogens. In particular, we develop multiplex PCR systems for the highly parallel detection of pathogens. On their basis, methods for the diagnosis of viruses, fungi and bacteria can be developed for customers from companies, hospitals and research institutions.

With many years of experience we develop microarrays based on nucleic acids or proteins as effective detection systems for pathogens of sepsis or skin infections, the detection of resistances or the diagnosis of respiratory diseases: from probe design to immobilization with contact printing methods.